Sponge delivery variables and tissue levels of 5-fluorouracil

被引:20
作者
Wilkins, MR
Occleston, NL
Kotecha, A
Waters, L
Khaw, PT
机构
[1] Inst Ophthalmol, Dept Pathol, Wound Healing Res Unit, London EC1V 9EL, England
[2] Moorfields Eye Hosp, Glaucoma Unit, London, England
关键词
D O I
10.1136/bjo.84.1.92
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim-To study how the delivery of 5-fluorouracil (5-FU) to ocular tissues is affected by altering delivery variables. Method-Sponge(s) soaked in radiolabelled 5-FU were placed between the conjunctiva and sclera of pig eyes. Application time, sponge size, sponge make (Altomed, Weck, Merocel), and 5-FU concentration were varied. Conjunctival and scleral tissue levels were determined in samples taken from the application site. Results-Dose-response curves for scleral and conjunctival 5-FU levels against application time showed increasing tissue levels that reached a plateau after 2-3 minutes. Application beyond 3 minutes did not increase tissue levels. There was no difference in tissue levels between 7x4 and 3.5x2 mm sponges. Altomed sponges produced 5-FU tissue levels that were twice as high as those obtained with Weck-cell (p<0.01) or Merocel (p<0.02) sponges. Changing the 5-FU concentration from 25 mg/ml to 6.25 mg/ml reduced the conjunctival concentration by at factor of 3.5 (p<0.003). Conclusion-Application time up to 3 minutes, sponge make, and 5-FU concentration can have a large effect on the tissue delivery of 5-FU. Application time beyond 3 minutes, using 3.5x2 mmr or 7x4 mm sponges, and replacing sponges every minute did not have a significant effect on tissue levels. This study models the effect that different variables can have on the ocular tissue levels of an antimetabolite applied intraoperatively.
引用
收藏
页码:92 / 97
页数:6
相关论文
共 40 条
[1]  
Alward WLM, 1996, AM J OPHTHALMOL, V121, P349
[2]  
CAMPAGNA JA, 1995, OPHTHALMIC SURG LAS, V26, P57
[3]   Trabeculectomy at the inferior limbus [J].
Caronia, RM ;
Liebmann, JM ;
Friedman, R ;
Cohen, H ;
Ritch, R .
ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (04) :387-391
[4]   TRABECULECTOMY WITH SIMULTANEOUS TOPICAL APPLICATION OF MITOMYCIN-C IN REFRACTORY GLAUCOMA [J].
CHEN, CW ;
HUANG, HT ;
BAIR, JS ;
LEE, CC .
JOURNAL OF OCULAR PHARMACOLOGY, 1990, 6 (03) :175-182
[5]  
Chen PP, 1997, J GLAUCOMA, V6, P192
[6]   A placebo-controlled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures [J].
Cohen, JS ;
Greff, LJ ;
Novack, GD ;
Wind, BE .
OPHTHALMOLOGY, 1996, 103 (11) :1934-1942
[7]  
Cordeiro MF, 1997, INVEST OPHTH VIS SCI, V38, P1639
[8]  
COSTA VP, 1993, OPHTHALMIC SURG LAS, V24, P389
[9]   EFFECTS OF TOPICAL MITOMYCIN-C ON PRIMARY TRABECULECTOMIES AND COMBINED PROCEDURES [J].
COSTA, VP ;
MOSTER, MR ;
WILSON, RP ;
SCHMIDT, CM ;
GANDHAM, S ;
SMITH, M .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1993, 77 (11) :693-697
[10]  
Costa VP, 1996, J GLAUCOMA, V5, P193